Immunohistochemistry (IHC) Cost Per Test, Service and Reagents.

The Defense Health Agency is conducting a pre-solicitation for immunohistochemistry (IHC) cost per test services and reagents for the Anatomic Pathology Laboratory at Naval Medical Center Portsmouth. The procurement includes on-site use of two automated immunohistochemistry stainers and one special stainer, along with appropriate consumable reagents and ready-to-use test kits. The government has issued a Notice of Intent to award this as a sole source contract to Roche Diagnostics, citing the proprietary nature of the technology that requires only Roche to perform certain maintenance and service procedures. The evaluation criteria focuses on whether potential respondents can demonstrate clear evidence that competition would be advantageous, cost-effective, and would not hinder mission objectives. Interested parties must submit responses to Contract Specialist Kimberly Bunn at kimberly.p.bunn.civ@health.mil with the subject line "Notice of Intent Submission 12150361" by July 30, 2025.

This procurement does not utilize any set-aside designations and is currently planned as a non-competitive award to Roche Diagnostics as the sole source contractor. The contract structure will include one base year running from October 1, 2025 through September 30, 2026, followed by four option years for a total potential contract duration of five years. The government file indicates this will be a Firm-Fixed-Price contract arrangement, though specific dollar values or budget ranges are not disclosed in the pre-solicitation documentation. The procurement specifically requires three pieces of specialized staining equipment along with associated consumables and test kits for the naval medical facility's pathology operations. The government emphasizes that this notice is not a request for quotes or proposals, and the final determination to proceed with non-competitive procurement remains at the government's discretion.